关注
Danko Jeremic
Danko Jeremic
PhD
在 uclm.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: A systematic review
D Jeremic, L Jiménez-Díaz, JD Navarro-López
Ageing research reviews 72, 101496, 2021
1732021
Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system
D Jeremic, I Sanchez-Rodriguez, L Jimenez-Diaz, JD Navarro-Lopez
Pharmacology & therapeutics 223, 107808, 2021
592021
Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta …
D Jeremic, JD Navarro-López, L Jiménez-Díaz
Ageing Research Reviews, 102012, 2023
192023
Impairments of synaptic plasticity induction threshold and network oscillatory activity in the hippocampus underlie memory deficits in a non-transgenic mouse model of amyloidosis
J Mayordomo-Cava, G Iborra-Lázaro, S Djebari, S Temprano-Carazo, ...
Biology 9 (7), 175, 2020
192020
Recognition memory induces natural LTP-like hippocampal synaptic excitation and inhibition
I Sánchez-Rodríguez, S Temprano-Carazo, D Jeremic, ...
International Journal of Molecular Sciences 23 (18), 10806, 2022
102022
Targeting epigenetics: a novel promise for Alzheimer’s disease treatment
D Jeremic, L Jiménez-Díaz, JD Navarro-López
Ageing Research Reviews, 102003, 2023
52023
Systematic characterization of a non-transgenic Aβ1–42 amyloidosis model: synaptic plasticity and memory deficits in female and male mice
R Jiménez-Herrera, A Contreras, S Djebari, J Mulero-Franco, ...
Biology of sex Differences 14 (1), 59, 2023
22023
Donanemab outperformed Aducanumab and Lecanemab on cognitive, but not on biomarker and safety outcomes: systematic review, frequentist and Bayesian network meta-analyses
D Jeremic, JD Navarro-Lopez, L Jimenez-Diaz
medRxiv, 2024.03. 31.24305134, 2024
2024
SYSTEMATIC CHARACTERIZATION OF A NON-TRANSGENIC AΒ1–42 AMYLOIDOSIS MODEL: SYNAPTIC PLASTICITY AND MEMORY DEFICITS IN FEMALE AND MALE MICE
R Jiménez-Hererra, A Contreras, G Iborra-Lázaro, D Jeremic, S Djebari, ...
IBRO Neuroscience Reports 15, S853, 2023
2023
ALZMETA. APP: ONLINE META-ANALYSIS OF MONOCLONAL ANTIBODIES AGAINST AMYLOID-BETA PEPTIDES IN LARGE PHASE III CLINICAL TRIALS IN ALZHEIMER'S DISEASE
D Jeremic, JD Navarro-López, L Jiménez-Díaz
IBRO Neuroscience Reports 15, S430, 2023
2023
A systematic review of therapeutic strategies against amyloid‐β peptides in Alzheimer’s disease: Past, present, and future
D Jeremic, L Jimenez‐Diaz, JD Navarro‐López
Alzheimer's & Dementia 19, e060438, 2023
2023
Systematic characterization of a non-transgenic Amyloid-beta1-42 amyloidosis model: synaptic plasticity and memory deficits in female and male mice
R Jimenez-Herrera, A Contreras, D Jeremic, G Iborra-Lazaro, S Djebari, ...
2023
Anti-amyloid antibodies in Alzheimer’s disease: what did clinical trials teach us?
D Jeremic, L Jiménez-Díaz, JD Navarro-López
Neural Regeneration Research, 10.4103, 0
系统目前无法执行此操作,请稍后再试。
文章 1–13